The Singapore Family Physician · 2019 · 30 citations · 9 references
PharmacyPharmacologyPharmacotherapyImmunopathologyInflammationInnate ImmunityAsthma ManagementAsthma PharmacotherapyCorticosteroid TherapyInflammatory Cell ResponsesInflammatory SignalingPulmonary InflammationAsthma Bronchodilator TherapyAsthma PathophysiologyAsthmatic Airway InflammationInflammatory Mediator PathwaysPatient Outcomes Measurement
Asthma is a chronic inflammatory airway disease, for which the cornerstone of asthma therapy is inhaled corticosteroids. however, long term clinical outcomes are variable, and not all patients respond optimally to corticosteroids. Underpinning this observation is that asthma is a heterogeneous disease consisting of phenotypes that are driven by different inflammatory pathways. In this article, we will discuss the different inflammatory mechanisms of asthma to better define patient characteristics and help improve patient outcomes with newer specific-targeted asthma therapies.
9
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
Romain Pauwels · Arerugī/Arerugi · 1996 · 10.1K citations
Pharmacy, Chronic Disease Prevention, Preventive Medicine +10
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
Kazuyo Moro, Taketo Yamada, M. Tanabe et al. · Nature · 2009 · 2K citations
Sally E. Wenzel, Lawrence B. Schwartz, Esther L. Langmack et al. · American Journal of Respiratory and Critical Care Medicine · 1999 · 1.2K citations